Field

medicine

Qatar’s leadership in field of precision medicine lauded

Qatar is in a position to translate the efforts in precision medicine for the last five years into clinical implementation, noted experts at a panel discussion on *Precision Medicine – One size doesn’t fit all, on the first day of WISH 2020.

“Qatar’s leadership has taken several measures for the last five years to set and create data for precision medicine through various programmes and research,” said Dr Said Ismail, director of the Qatar Genome Programme, at the panel discussion.
“We spent a lot of time and efforts to introduce data for researchers and for programmes for universities to pave the way for precision medicine,” he said. “Now it is the right time to harness on what we have achieved and produced over the last five years. It is the time to shift from producing data to implement the outcomes at the clinical side.”
“This will basically show the patients that this can impact their life or the healthcare they are receiving,” he explained. “You also have to choose your models where you want to start to show the impact.
“The Qchip we are producing is another example as it consists of summary of variants that we have studied in the Qatari population and they are related to wide array of diseases.”
The panel discussion was also accompanied by the launch of a report by the Economist Intelligence Unit (EIU), titled *Doing Well? Fulfilling the Promise of Precision Medicine.
The report, sponsored by Qatar Foundation, discusses the promise of precision medicine, what it is currently delivering, and challenges associated with its wider application in large health systems.
The report notes that precision medicine, while still work-in-progress, has shown promising potential, particularly in areas like oncology and rare diseases.
It has allowed better understanding of tumour genetics resulting in more effective treatments – particularly for lung and breast cancer.
For rare diseases, genomic sequencing has drastically reduced diagnosis times from years to a matter of months, sometimes even weeks.
David Humphreys, global head of Health Policy at EIU, said: “Our focus with the study was really looking at that long talked about promise of better, more targeted care for patients and ongoing basis.
“It really focused on two critical aspects that we consider to be important.
“The first is integration into the patient centricity movement, and the second is the concept of return on investment and value demonstration.
“Much has been said about precision medicine generating savings, and there is also evidence.”
The report hints that perhaps the biggest challenge will be developing a workforce capable of delivering precision medicine, including integration of specialists – notably geneticists, genetic counsellors, and data into the existing healthcare system.
“When we look at the policy briefs we have drafted, we wanted to make sure that it addresses strategy as well as policies, and one aspect of that is to harmonise the activities among the different players,” said Walid Qoronfleh, director of Healthcare Research and Policy at WISH.
“Another important aspect is the integration of

Read More
medicine

Functional Medicine is Making Waves in the Medical Field – Press Release

Functional Medicine is Making Waves in the Medical Field

All medicine is created equal, correct? It may surprise patients to learn that not every treatment is right for every person. For decades, patients in Atlanta, GA, have relied on conventional medicine to diagnose and treat their ailments. However, it may not be the best choice for everyone. Here’s why functional medicine is becoming more popular for patients of all ages.

A Better Way to Treat Illness

When a patient visits a conventional doctor, they describe their symptoms and wait for a diagnosis. The doctor uses this information to develop a treatment plan. In most instances, these appointments only last a few minutes, and the doctor doesn’t push the patient for more information.

While it’s possible to correctly diagnose and treat a variety of illnesses in this manner, it’s not always the best option. Patients often fail to tell their physician about other factors that may play a role in their health, and some people only continue to get worse after diagnosis. Functional medicine bridges this gap.

What is functional medicine? It’s a comprehensive way to determine and treat the root cause of a patient’s illness. According to https://www.progressivemedicalcenter.com/functional-medicine/, functional medicine is a patient-focused approach. It goes beyond symptoms to create a personalized treatment plan.

How Functional Medicine Works

Functional medicine is a collaborative approach to health care. Instead of relying on a single physician for treatment, patients also receive advice from other medical professionals. According to https://www.progressivemedicalcenter.com/, naturopathic doctors and dietitians are some of the most common. Combining the knowledge of several medical experts provides patients with a more comprehensive diagnosis and more advanced treatment options.

For example, if a physician discovers a patient has high cholesterol after running a series of tests, they may prescribe a medication to lower it. However, without also addressing the patient’s lifestyle and dietary habits, the medicine will only mask the problem. Functional medicine lets doctors work together to find and treat the root cause of an illness or disorder.

Is Functional Medicine Right for Everyone? 

Patients often hit a brick wall when it comes to treating illnesses. Why aren’t they getting better? Are there other treatments out there? Since functional medicine looks past symptoms to figure out what’s really going on, patients can often reach their health goals faster than before.

Functional medicine isn’t a new approach to medicine; it’s just a better approach. Patients still have access to highly-skilled doctors, but they’ll also be able to meet with other medical experts to obtain different opinions. Appointments are more thorough, and doctors ask questions to learn as much about the patient as possible. Getting to know the entire person instead of just the symptoms makes this approach better for most people.

A Functional Approach to Better Health

Progressive Medical Center is an integrative medical center, providing functional medicine to patients since 1998. Using a whole-person approach, the doctors offer advanced diagnostics and comprehensive solutions to every patient. It’s their goal to help people regain their health through customized therapies and proven remedies.

Read More
medicine

Cabinet approves MoU between India, Israel on cooperation in field of health and medicine

New Delhi [India], November 4 (ANI): The Union Cabinet chaired by Prime Minister Narendra Modi has approved the signing of the Memorandum of Understanding (MoU) between India and Israel on cooperation in the field of health and medicine.

According to a press statement from the cabinet, the MoU covers areas of cooperation in “Exchange and training of medical doctors and other health professionals”.

It covers areas of cooperation in “Assistance in development of human resources and setting up of health care facilities; exchange of information regarding regulation of pharmaceutical, medical devices and cosmetics; sharing expertise for vulnerability assessment for health of citizens against climate risk and public health actions targeted towards mitigation and adaptation.”

As per the statement, the MoU covers areas of cooperation in “Sharing of expertise for facilitating climate resilient infrastructure as well as providing support for development of ‘Green Healthcare’ (climate-resilient hospitals); promote mutual research in various relevant areas; and any other area of cooperation as may be mutually decided upon.”

Each party shall encourage the participation of the representatives of their countries in round tables, seminars, symposia, workshops and conferences on issues of cooperation, organised by the other party’s relevant bodies, the press statement added. (ANI)

Source Article

Read More
medicine

Developments in the Field of Regenerative Medicine & Rising Demand for Minimally Invasive Surgeries

DUBLIN, Oct. 28, 2020 /PRNewswire/ — The “Global Sports Medicine Market by Product (Body Reconstruction, Body Support & Recovery), Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries), End User (Hospitals, Physiotherapy Centers & Clinics) and Region – Analysis & Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The global sports medicine market is projected to reach USD 7.2 billion by 2025 from USD 5.5 billion in 2020, growing at a CAGR of 5.7%.

This report studies the sports medicine market based on product, application, region and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders.

Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

“The Body Support & Recovery Products segment is expected to grow at the highest rate during the forecast period.”

On the basis of product, the global sports medicine market has been segmented into body reconstruction products, body support & recovery products, and accessories. The body reconstruction products segment is further divided into fracture and ligament repair products, arthroscopy devices, implants, prosthetics, and orthobiologics.

Similarly, body support & recovery products include braces & support, physiotherapy equipment, and compression clothing. The body reconstruction products segment is expected to grow at the highest CAGR during the forecast period. Braces & supports are required before and after procedures involving reconstruction. The demand for these devices is growing due to their requirement in the treatment of the majority of the sports injuries.

“The knee injuries segment is expected to hold the largest share during the forecast period.”

On the basis of application, the sports medicine market is segmented into knee injuries, shoulder injuries, foot & ankle injuries, elbow & wrist injuries, back & spine injuries, hip & groin injuries, and other injuries. The knee injuries segment is expected to account for the largest share of this market. The large share of this segment can be attributed to knee injuries being the most common sports injury accounting for approximately 40% of all injuries.

“The Hospitals segment is expected to account for the largest share during the forecast period.”

Based on end user segment, the market is segmented into Hospitals, Ambulatory Surgery centers and Physiotherapy Centers and Clinics. The hospitals segment accounted for the largest share of the sports medicine market. The large share of this segment can be attributed to factors like Complex diagnostic and therapeutic procedures being carried out in hospitals.

“The North American sports medicine market is expected to hold the largest market during the forecast period.”

Geographically, the sports medicine market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The North American market is expected to hold the largest share while Asia Pacific is to account for the highest

Read More
medicine

Global Sports Medicine Market 2020-2025: Developments in the Field of Regenerative Medicine & Rising Demand for Minimally Invasive Surgeries

DUBLIN, Oct. 28, 2020 /PRNewswire/ — The “Global Sports Medicine Market by Product (Body Reconstruction, Body Support & Recovery), Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries), End User (Hospitals, Physiotherapy Centers & Clinics) and Region – Analysis & Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The global sports medicine market is projected to reach USD 7.2 billion by 2025 from USD 5.5 billion in 2020, growing at a CAGR of 5.7%.

This report studies the sports medicine market based on product, application, region and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders.

Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

“The Body Support & Recovery Products segment is expected to grow at the highest rate during the forecast period.”

On the basis of product, the global sports medicine market has been segmented into body reconstruction products, body support & recovery products, and accessories. The body reconstruction products segment is further divided into fracture and ligament repair products, arthroscopy devices, implants, prosthetics, and orthobiologics.

Similarly, body support & recovery products include braces & support, physiotherapy equipment, and compression clothing. The body reconstruction products segment is expected to grow at the highest CAGR during the forecast period. Braces & supports are required before and after procedures involving reconstruction. The demand for these devices is growing due to their requirement in the treatment of the majority of the sports injuries.

“The knee injuries segment is expected to hold the largest share during the forecast period.”

On the basis of application, the sports medicine market is segmented into knee injuries, shoulder injuries, foot & ankle injuries, elbow & wrist injuries, back & spine injuries, hip & groin injuries, and other injuries. The knee injuries segment is expected to account for the largest share of this market. The large share of this segment can be attributed to knee injuries being the most common sports injury accounting for approximately 40% of all injuries.

“The Hospitals segment is expected to account for the largest share during the forecast period.”

Based on end user segment, the market is segmented into Hospitals, Ambulatory Surgery centers and Physiotherapy Centers and Clinics. The hospitals segment accounted for the largest share of the sports medicine market. The large share of this segment can be attributed to factors like Complex diagnostic and therapeutic procedures being carried out in hospitals.

“The North American sports medicine market is expected to hold the largest market during the forecast period.”

Geographically, the sports medicine market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The North American market is expected to hold the largest share while Asia Pacific is to account for the highest

Read More
medicine

Psychedelics startups racing to go public: Compass, Havn, Field Trip

  • There is a “psychedelics renaissance” in motion, according to insiders in the industry, as shown by a rush of investor dollars and a number of public market debuts.
  • Some of the investors and banks working in psychedelics are the same ones who were involved with the cannabis boom and subsequent bust.
  • Despite the similarities, psychedelics insiders say that there are stark differences between cannabis and psychedelics.
  • Business Insider spoke to five industry insiders, from company CEOs to investors. They said they don’t see psychedelics facing the same pitfalls that befell the cannabis industry.
  • Subscribe to Insider Cannabis for more stories like this.

The psychedelics industry is booming.

Compass Pathways, a London-based psychedelics giant, raised $146.6 million in its US initial public offering last month, and is valued at more than $1 billion. Psychedelics companies Field Trip Health and Havn Life Sciences recently started trading in Canada, following MindMed, which secured a Canadian listing in March.

Meanwhile, the psychedelics industry is drawing attention from biotech investors, as well as from cannabis companies looking for fresh opportunities.

The total market for psychedelics-related medicines could eventually reach $100 billion, according to a report from Tania Gonsalves at Canaccord Genuity. Companies are working on psychedelics-based therapies for treatment-resistant depression, cluster headaches, opioid use disorder, smoking cessation, and PTSD among others, according to the report.

Ronan Levy, the founder and executive chairman of Field Trip, which is focused on setting up treatment clinics and on psychedelics-based drug development and manufacturing, called the uptick in investor interest and funding a “psychedelic renaissance.”

A focus on the importance of mental health has gone mainstream, Levy said. Other factors driving the boom include increasing research on psychedelics, big-name investors like Peter Thiel coming on board, skepticism around big pharma, and the headway that cannabis has made in challenging preconceived notions of drugs, he said.

The psychedelics boom has some parallels with the cannabis bubble

Levy’s firm started trading on the Canadian Securities Exchange on Oct. 6. Cannabis-focused asset manager Silver Spike Capital and Harris Fricker, the former CEO of GMP Capital, invested in the company before it went public.

GMP Capital is a Canadian investment bank that advised cannabis companies including Canopy Growth. Its capital-markets business was acquired by Stifel Financial in December 2019. Other Canadian investment banks that work with cannabis companies, such as Canaccord Genuity and Eight Capital, are now starting to advise psychedelics companies as they gear up to trade publicly.

“I think you have a lot of people who have seen what has happened in the cannabis industry from a capital markets perspective, seeing psychedelics as an extension of it,” said Levy. “You have a lot of people who either made a lot of money or were very interested in the cannabis industry, seeing the cannabis industry going through a bit of a trough from a valuation perspective and a reputational perspective and they’re looking for another great opportunity.”

Though there are some parallels between cannabis and psychedelics, they don’t run as deep as

Read More